Clinical and Electrophysiological Characteristics of Patients with Juvenile Absence Epilepsy in a Turkish Cohort
Öz
Juvenile absence epilepsy is an epileptic syndrome that usually begins between the ages of 9-13 and is classified in the group of genetic generalized epilepsies, in which absence seizures are seen mainly but may also be accompanied by motor seizures in the follow-up. In our study, 33 patients who were followed up in our clinic with the diagnosis of juvenile absence epilepsy between 2010-2022 were evaluated retrospectively. Thirteen of them were excluded from the study due to insufficient clinical or electrophysiological knowledge, being diagnosed with another epileptic syndrome during follow-up. The mean age of the 20 patients included in the evaluation was 16.8 years; The mean age of seizure onset was 10.6 years. All patients had absence seizures, which were not seen more often than once a day, 40% had additional generalized tonic-clonic seizures, and 20% had focal electroencephalographic abnormalities in addition to generalized discharges on electroencephalography. Seizures recurred in 3 of 5 patients whose treatment was terminated. It was found that currently 85% of the patients continued treatment with valproic acid and monotherapy was sufficient. While there are generalized discharges at the time of diagnosis electrophysiologically, focal findings tend to occur in the follow-up; This was also found to be important in the evaluation of seizure recurrence and treatment options in patients with long-term follow-up.
Anahtar Kelimeler
Juvenile absence epilepsy, Electroencephalography, Valproic acid
Kaynakça
- 1. Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: Position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):522-530. doi: 10.1111/epi.13670
- 2. Wirrell EC, Nabbout R, Scheffer IE, et al. Methodology for classification and definition of epilepsy syndromes with list of syndromes: Report of the ILAE task force on nosology and definitions. Epilepsia 2022;63(6):1333-1348. doi: 10.1111/epi.17237
- 3. Nordli Jr. DR. Idiopathic generalized epilepsies recognized by the International League Against Epilepsy. Epilepsia. 2005;46(9):48-56. doi: 10.1111/j.1528-1167.2005.00313.x
- 4. Asadi-Pooya AA, Farazdaghi M. Seizure outcome in patients with juvenile absence epilepsy. Neurol Sci. 2016;37(2):289-292. doi: 10.1007/s10072-015-2411-y
- 5. Healy L, Moran M, Singhal S, O’Donoghue MF, Alzoubidi R, Whitehouse WP. Relapse after treatment withdrawal of antiepileptic drugs for juvenile absence epilepsy and juvenile myoclonic epilepsy. Seizure. 2018;59:116-122. doi: 10.1016/j.seizure.2018.05.015
- 6. Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disorders. 2007;9(4):353-412. doi:10.1684/epd.2007.0144
- 7. Tovia E, Goldberg-Stern H, Shahar E, Kramer U. Outcome of children with juvenile absence epilepsy. J Child Neurol. 2006;21(9):766-768. doi:10.1177/08830738060210092101
- 8. Boesen MS, Børresen ML, Christensen SK, et al. School performance and psychiatric comorbidity in juvenile absence epilepsy and juvenile myoclonic epilepsy: A Danish population-based cohort study. J Neurol. 2022;269(9):4997-5007. doi:10.1007/s00415-022-11147-2
- 9. Thakran S, Guin D, Singh P, et al. Genetic Landscape of Common Epilepsies: Advancing towards Precision in Treatment. Int J Mol Sci. 2020;21(20):7784. doi:10.3390/ijms21207784
- 10. Aiguabella Macau M, Falip Centellas M, Veciana de Las Heras M, et al. Long term prognosis of juvenile absence epilepsy. Neurologia. 2011;26(4):193-199. doi:10.1016/j.nrl.2010.09.005